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Purpose: To develop a numerical approach for estimation
of vascular permeability from dynamic T2*-weighted imag-
ing, a technique routinely used to measure cerebral blood
volume (CBV) and flow in gliomas.
Materials and Methods: This study describes a process for
estimating both the gadolinium diethylenetriamine penta-
acetic acid (Gd-DTPA) transvascular transfer constant and
CBV from dynamic T2*-weighted images. The algorithm
was applied to data from the brains of 12 patients with
grade IV gliomas. The stability of the method was assessed.
Estimates of CBV by this technique were compared to those
of the conventional method.
Results: The algorithm was found to be insensitive to noise
and to generate stable voxel-by-voxel estimates of perme-
ability and CBV.
Conclusion: Using a single imaging acquisition, the three
most important vascular properties, CBV, cerebral blood
flow (CBF), and permeability, can be estimated. This ap-
proach may have potential in clinical evaluation of patients
with brain tumor or acute ischemic stroke.
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VASCULAR PERMEABILITY to a contrast agent is a
potentially valuable measurement for evaluating cancer
therapy efficacy and/or related normal tissue toxicity.
Most pharmacokinetic modeling of vascular permeabil-
ity is based upon dynamic contrast-enhanced (DCE) T1
MR measurements (1–3). Although some concerns re-
main in the estimation of contrast agent concentrations
using DCE T1 measures (4–6), the methodologies for
permeability quantification have been reviewed and a
consensus has been reached (7). Interest in estimating
vascular permeability to gadolinium diethylenetriamine
pentaacetic acid (Gd-DTPA) from DCE T2*-weighted im-
ages has recently increased (8), driven primarily by clin-
ical research interests in obtaining perfusion parame-
ters of cerebral blood volume (CBV) and cerebral blood
flow (CBF), along with a measure of the vascular per-
meability estimate in a single bolus contrast injection.
Single-shot T2*-weighted DCE is commonly utilized for
whole-brain mapping of CBV and CBF, especially in
clinical settings, due to its high temporal resolution
(one to two seconds) and tissue coverage; whereas T1-
sensitive DCE acquisition is desirable to measure per-
meability. Competing factors, however, make it difficult
to accentuate both T1 and T2* contrast during the pas-
sage/leakage of an intravascular agent, so that typi-
cally only one contrast type is selected for a given injec-
tion. Ideally, two contrast injections are performed in
separate series to independently determine permeabil-
ity and blood volume/flow. This may add significant
cost, scan time, and protocol complexity, and thus two-
injection MRI exams are usually not performed. As a
potential practical alternative, estimation of CBV has
been proposed from a T1-weighted DCE images series
based on signal enhancement during the first pass of a
bolus while it is still confined to the vasculature (9).
This is not ideal, since T1-weighted techniques typically
do not have the temporal and spatial resolution of T2*-
weighted echo-planar imaging (EPI). In another ap-
proach, both T1- and T2*-sensitive images are simulta-
neously acquired by dual gradient-echo dynamic
imaging (10,11), but this method requires a tradeoff
between the temporal and spatial resolution. Con-
versely, contrast leakage into the extravascular space
alters signal on T2*-weighted images so that it may be
possible to derive vascular permeability by analysis of
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agent recirculation and equilibration during the latter
time points of a dynamic T2*-weighted series (8). The
objective of the work presented here was to investigate
the performance of a new algorithm for deriving perme-
ability information from a dynamic T2*-weighted image
series. While quantification of multiple vascular prop-
erties from a single injection has substantial practical
appeal, the stability and accuracy of such measures
performed on a voxel-by-voxel basis is difficult to pre-
dict without clinical trials. Moreover, a hybrid approach
is not anticipated to exceed the performance of dedi-
cated (i.e., two-injection) methods, but the tradeoffs
may be tolerable and permit retrospective estimation of
additional useful properties.
The theoretical framework for correction and ultimate
utilization of T1 enhancement in predominately T2*-
weighted images has been described by others (12).
Nevertheless, using T2*-weighted images to obtain sta-
ble and reproducible voxel-by-voxel estimates for
blood-to-brain/tumor permeability to a MR contrast
agent remains a challenge. A method proposed by Weis-
skoff et al (12), and modifications of that work (13,14),
were primarily designed to correct the influence of T1
enhancement on the estimate of CBV; the method was
later used for the estimate of vascular permeability in a
clinical application (15). The effect of T1 enhancement
on the estimate of CBV, however, can be substantially
reduced by using T2* instead of T2 measures, long TR,
small flip angle, and relatively low contrast dose. Note
that in Weisskoff’s methods, back-flux of the contrast
agent from extravascular extracellular space (EES) to
the vascular space was neglected; at high values of
permeability, this can cause estimates to be biased
toward lower values (6). Several other methodologies
have also been proposed to simultaneously quantify
permeability and CBV from dual gradient-echo dy-
namic images (10,11). Again, in these studies, the
back-flux of the tracer was neglected. As a drawback,
dual gradient-echo dynamic imaging has limited speed,
so the investigators often trade spatial resolution or
coverage (one to two slices) for temporal resolution
(1–2 seconds per frame).
A recent methodology (8) has been presented in which
the contrast concentration–time curve was determined
from normal white matter, the back-flux of the tracer
from the EES to the vascular space was considered, and
the difference between intravascular and extravascular
contrast-induced susceptibilities was neglected. This
approach was able to qualitatively differentiate pathol-
ogies with different vascular properties. However, the
technique is very sensitive to signal-to-noise and fails to
produce voxel-by-voxel permeability or CBV corrected
for vessel leakage.
Combining elements from these earlier works, we
propose an iterative approach to estimate, voxel-by-
voxel, the permeability map and CBV map from dy-
namic T2*-weighted MR images. The algorithm is ap-
plied to estimate the transfer constant of Gd-DTPA and
CBV in the brains of 12 patients with grade IV gliomas.
The estimate of CBV by this technique is compared to
that calculated by a conventional method (16). The sta-
bility of the algorithm is assessed by simulated data.
Results indicate the algorithm is insensitive to noise
and can generate stable estimates of permeability and
CBV on a voxel-by-voxel basis (17).
MATERIALS AND METHODS
Theory
The total tissue concentration of an extracellular con-
trast agent can be described as (7)





where C denotes the tracer concentration, v depicts the
fractional volume, subscripts t, p, and ees represent
respectively tissue, plasma, and EES, Ktrans is the trans-
fer constant of the agent influx from the plasma to the
EES, and kep is the tracer efflux rate from the EES to the
plasma. The fractional volume of the EES can be deter-
mined from the ratio of Ktrans to kep.
Bolus Shape Function
The first-pass bolus shape function has been described
by a gamma variate g(t) plus an integral term (8,12):
sinpt  Agt  
0
t
gt  d, (2)
where
gt  t  t0
 exp  	t  t0 for
t  t0, otherwise gt  0. (3)
In most proposals (8,10–14), the recirculation
“bump” in the bolus shape function has been neglected.
However, in almost all cases we have examined, the
second pass closely follows the first pass (Fig. 1). Ne-
glecting the second pass can result in substantial er-
rors in estimates of Ktrans (Fig. 1d). Thus, an additional
term that describes the second pass was added to the








 are parameters adjusted for the
time shift, width, and amplitude, respectively, of the
bolus’ second pass.
Algorithm
Our fitting process consists of five steps:
1. Assume Ktrans is zero and vp is 1% in normal white
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Fitting Eq. [5] to the data in volumes of interest
(VOIs) of normal white matter yields eight param-
eters (, 	,  t0, and A for the first pass, and t0
, thalf,
and A
 for the second pass) that describe the bolus
shape function.
2. For the first estimate of vp in each voxel, a rapid
increase in Ct up to the peak of the first pass is
assumed to be predominately due to contrast
agent in the intravascular space. This assumption
is consistent with the computation of the CBV by
the conventional algorithm (16). In addition, a pos-
sible time shift of the input function in a voxel is
considered and quantified compared to that in
normal white matter. However, the change in the
width of the input function is omitted due to the
fact that there is insufficient information to deter-
mine it. With these assumptions, the input func-





Fitting the temporal data up to the peak of the first




3. Before computing Ktrans, the presence of significant
vascular leakage in each voxel is assessed. The
difference of the total contrast concentration in a
voxel and the contribution of the vascular volume
to the concentration in the voxel (see Fig. 2) is
determined by
Figure 1. Contrast concentration–time
curves in normal white matter of three
patients (a–c). Note that the recircula-
tion of the contrast bolus follows the first
pass very closely. The intensity of the
recirculation “bump” is significantly
greater than that in the tail (d). For var-
ious shapes of the contrast concentra-
tion-time curves, accurate fits (solid
lines) can be obtained from Eqs. [2]–[4].
If only the first pass is considered, the
residual sum of squares of errors (d) can
be an almost order magnitude greater
than that of fitting both the first- and
second-bolus passes (c).
Figure 2. a: Shows the transfer constant map esti-
mated by fitting both the first and second passes of the
bolus in the input function. b: Shows the difference
between the transfer constant maps estimated by fitting
both the first and second passes of the bolus and ne-
glecting the recirculation; positive values are shown in
the tumor volume (black contour), suggesting that ne-
glecting the recirculation yields an underestimate of the
transfer constant.








vox exp  kept  d (7)
If Eq. [7] is significantly greater than zero, it indi-
cates that Ktrans is detectable (discernable from
noise). Otherwise, fitting Ktrans can cause unstable
results and errors in both Ktrans and vp. Thus, a
t-test is used to evaluate Eq. [7]. The mean and
standard deviation (SD) of the different signals in
Eq. [7] from the time at the peak of the first pass of
the bolus to the end of the time curve are calcu-
lated. Then, a t-value is calculated as the ratio of
the mean to the standard error of the mean (SEM).
If the t-value is significantly greater than zero (one-
tailed t-test; P  0.05), the computation continues
for step 4, and if not, Ktrans and kep are assigned to
be zero and the program stops.
4. Fit Eq. [7] for the second half of the curve (starting
from the peak) to obtain the first estimates of Ktrans
(1)
and kep
(1) while keeping vp
vox(1) and t0
wox fixed.
5. Refit the whole curve for Ktrans, Kep, and vp by al-
lowing perturbations of the values obtained from
steps 2 and 4 with fixed t0
wox.
MRI Experiment and Subjects
Retrospective analysis was performed on dynamic T2*-
weighted images acquired in 12 patients with grade IV
glioma participating in a clinical protocol approved by
the internal review board. The images were acquired
one to two weeks prior to radiotherapy, but two to four
weeks after surgery (either partial resection or biopsy
only). Informed consent was obtained from all of the
patients prior to the study.
All images were acquired on a 1.5-Tesla clinical MRI
scanner (General Electric Medical Systems, Milwaukee,
WI, USA). A total of 36 volumes of dynamic T2*-
weighted images were acquired by a gradient-echo EPI
pulse sequence with TR  2 seconds, TE  60 msec,
field-of-view  220  220 mm2, matrix size  128 
128, flip angle  60°, and 14 interleaved slices with
thickness  6 mm and gap  0 mm. Gd-DTPA (0.1
mL/kg) was injected intravenously by a power injector
with a rate of 2 mL/second, followed immediately by 15
mL of saline flush at the same rate.
The paramagnetic contrast agent that has been pre-
viously used for estimates of CBV and CBF (16,20,21)
gives rise to a change in R2*, which has been (either
implicitly or explicitly) assumed to be proportional to
the intravascular contrast concentration (16,20,22) as
R*2intra  intraCp (8)
where intra is the proportional factor, and Cp is the
plasma contrast concentration. The effective R2*
change in a voxel that contains both intravascular and
extravascular contrast agents can be approximated as
R*2eff  effCt (9)
where eff is the effective proportional factor, and Ct is
the total contrast concentration in tissue. Given that
the R2* effect depends upon the size of the contrast
distribution space (23), intra and eff may be different,
and given the difficulty of constructing model systems
representative of capillary vascular beds, not easily de-
termined by in vitro studies. Using Eq. [1], [8], and [9],












R*2intraexp  kept  0d, (10)
where Eq. [10] is similar to Eq. [1], except that v
p and
K
trans are scaled by the ratio of eff to intra. For a voxel
that contains no leaky vessels, the ratio is equal to one.






where So and S are the signal intensities acquired before
and after the contrast bolus injection, respectively.
Numerical Computation
All software programs were developed in-house using
C. Prior to computations for K
trans and v
p, acquisi-
tion time differences between sections within a single
volume were corrected by cubic spline interpolation (24)
to match the time of the first slice acquired in each
volume. All of the fitting described in the Theory section
was done by minimizing the residual sum of squares of
errors using a simplex search algorithm (24).
To estimate the parameters (up to eight) of the input
function, a typical VOI of normal white matter was
selected, containing 500–800 voxels that had a con-
trast-noise ratio (CNR) of 100–150. CNR is defined as
the difference in signal intensities between the peak of
the first pass of the bolus and the baseline average
divided by the SD of the baseline signal intensities.
Several guidelines were used for selection of the white
matter VOI: 1) normal appearance in T2-weighted im-
ages; 2) contralateral to the tumor; 3) as large as pos-
sible but avoiding partial volume averaging with gray
matter and cerebrospinal fluid (CSF); and 4) avoiding
regions degraded by susceptibility artifact. Also, voxels
that had signal intensities 2SD above or below the
mean were rejected from the VOI. To obtain the eight
parameters of the input function, the residual sum of
squares of errors from fitting the white matter VOI was
minimized iteratively until the relative change between
two subsequent iterations was less than 1  10–8, a
process which took about six to eight seconds. A similar
iterative procedure was also applied to fit individual
voxels, for which two parameters were fitted in step 2
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(p
vox(1) and t0
wox) and step 4 (Ktrans
(1) and kep
(1)), and three
parameters in step 5 (Ktrans, kep, and vp).
Stability Test
The stability of the fitting algorithm is crucial for its
usefulness in a clinical trial. Thus, the stability was
tested by computer simulated data, in which vp was 1%,
Ktrans varied from 0.001 to 0.5 minute
–1, and vees was
15%. For the clinical data obtained, the single-voxel
CNR in the tumor varied from 18 to 50. Thus, Gaussian
noise was added to the simulated contrast concentra-
tion–time curves to have CNR of 20, 50, 100, and infi-
nite at the peak of the first passage of the bolus. The
simulated contrast concentration–time curve contained
36 points with two seconds per point, which matched
the clinical data that we obtained. For each combina-
tion of the tested parameters and noise levels, 4096
simulations were conducted. The SD of the 4096 sim-
ulations per condition was computed and was used as
a metric to assess the stability of the algorithm.
RESULTS
Contrast concentration–time curves in the normal
white matter of three patients, and their fitting results
using Eqs. [2]–[4], are shown in Fig. 1. If the recircula-
tion pass is ignored, there is substantial discrepancy
between the fitting result and the empirical data (Fig.
1d). For the example shown in Fig. 1c and d, the resid-
ual sum of squares of errors obtained by fitting the first
pass only was 1.1  10–3, almost an order of magnitude
greater than the value of 1.4  10–4 that was obtained
by fitting both the first and second passes (Fig. 1c). This
error affects the estimate of K
trans. The K
trans value
obtained by fitting both the first and second passes of
the bolus was approximately 22% greater than that
obtained by fitting the first pass only (Fig. 2); while
estimates of v
p obtained by the two fittings were very
close (3% in difference), as expected. For the case
shown in Fig. 2, the mean K
trans in the tumor volume
defined on the fluid attenuation inversion recovery
(FLAIR) images were 0.028 and 0.023 minute–1 with
and without fitting the recirculation “bump,” respec-
tively.
In our algorithm, after the initial estimates of vp and
t0
vox for an individual voxel or VOI (step 2), the difference
between a total of the contrast concentration and the
intravascular concentration described by Eq. [7] was
evaluated to determine whether there was a significant
extravascular contrast concentration, defined as the
area under the temporal curve after the first-pass peak
significantly differing from zero (Fig. 3b). The extravas-
cular contrast concentration-time curves from a VOI
and a voxel in the tumor volume were significantly
greater than zero (P  0.05), while the data from an-
other VOI and a voxel in the region contralateral to
tumor were not (P  0.05). For the latter VOI and voxel,
K
trans was assigned to be zero. For the first VOI and
voxel, the fitting procedure continued to steps 4 and 5.
The final fitting results are shown in Figs. 4 and 5.
An example of K
trans and v
p (CBV) maps in a patient
with grade IV glioma reconstructed by our algorithm is
shown in Fig. 4. Note that only the rim of the tumor has
significant nonzero K
trans. CBV maps reconstructed by
our algorithm are similar to the CBV estimated by the
conventional method without correction for vascular
leakage (Fig. 5) (16). A scatter-plot of the two CBV maps
shown in Fig. 5c has a correlation coefficient of 0.83,
slope of 0.86, and intercept of 0.27%. As expected, the
relative differences of the two CBV maps are similar to
the K
trans maps (Fig. 5). Particularly, in the tumor re-
gion, the CBVs estimated by our algorithm are smaller
than those obtained by the conventional method; in the
latter, extravascular contrast agent, is at least partially
accounted for as intravascular contrast agent.
In the 12 patients with grade IV gliomas, the averaged
K
trans over the tumor volume that was defined on FLAIR
images but excluding voxels having zero K
trans
Figure 3. a: Shows contrast concentration–time curves in a VOI (TumorVOI) and a voxel (TumorVox) in the tumor region and
a VOI (ContraVOI) and a voxel (ContraVox) in the region contralateral to tumor normalized by their fractional volumes of CBV.
The solid, dotted, dash, and dotted-dash lines show the fitting results. b: Plots show the differences of a total of the contrast
concentrations and the intravascular contributions to the concentration, presumably the extravascular tracer concentrations
described by Eq. [7], in the two VOIs and two voxels. c: Shows the locations of the two VOIs and the two voxels, and arrows point
to the voxels. Note that only the differences from the VOI and the voxel in the tumor region are significantly greater than zero (P 
0.05), whereas those from the region contralateral to tumor are not.
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(0.0002 minute–1) ranged from 0.12 minute–1 to 0.02
minute–1, the group mean of 0.07 minute–1  0.03
minute–1. Similarly, the average v
p over the tumor vol-
ume ranged from 4.7% to 1.7%, with a group mean of
2.7% 0.9% (Table 1). SDs of K
trans in individual tu-
mors are also given in Table 1, and are on the order of
magnitude of K
trans itself, suggesting heterogeneous
vascular leakage in the tumor volume.
The stability of the algorithm was tested by computer
simulated data. For Ktrans of 0.5 to 0.02 minute
–1 and
four different CNRs, the ratio of the SD to the mean was
less than 7%. For Ktrans of 0.01 minute
–1, the ratio was
less than 11%, while for 0.005 minute–1, the ratio was
less than 33%. For Ktrans of 0.002 and 0.001 minute
–1,
the ratio was less than 33% for CNR greater than or
equal to 50 and was greater than 100% for CNR of 20
(Fig. 6).
DISCUSSION
Accurately and consistently fitting the shape of the in-
put function from normal white matter is crucial to
minimize the error in voxel-by-voxel estimates of the
transfer constant based upon dynamic T2*-weighted
images. As demonstrated in Fig. 1, our algorithm elim-
inates the error associated with second-pass contrast
recirculation. Successfully fitting the contrast agent re-
circulation reduced the residual sum of squares of er-
rors by almost an order of magnitude compared to ne-
glecting the recirculation. This error can greatly impact
the estimate of the transfer constant, which is approx-
imately 22% underestimated, as evidenced in Fig. 2. In
order to fit the second pass, three additional parame-
ters (A
, t0
, and thalf) were introduced to describe the
width, height, and onset time of the second pass. Al-
though there are up to eight parameters involved in
fitting the input function from white matter, the CNR
(approximately 150 at the peak of the curve) of the
normal white matter curve obtained from a VOI that
typically contains 500–800 voxels is sufficient for fit-
ting. If in the case that there is no recirculation bump
(we saw one such case out of 12 patients), A
 (the am-
plitude of the recirculation bump) can be either manu-
ally or automatically set to zero. The ability to detect
these eight parameters, although they are independent,
can be influenced by the temporal resolution and the
signal-to-noise ratio of the input function. However, it is
worthwhile to point out that the accuracy in the fitting
of the shape of the input function, determined by the
mean squares error, affects the subsequent estimates
of the transfer constant and the blood volume, but the
precision of the individual parameters of the input
function do not. Also, when the eight parameters are
fitted, the shape of the input function is determined and
is not altered (expect a possible time-shift) in the fitting
for the transfer constant and the blood volume.
Figure 4. Maps of the transfer constants of Gd-DTPA (left panel) and the fractional volume of plasma (right panel) reconstructed
by our algorithm. Note that only the rim of the tumor (arrowheads) in this patient shows an increase in the blood-brain/tumor-
barrier permeability.
Figure 5. Two CBV maps of a patient with grade IV glioma with one reconstructed by our algorithm (a) and another by the
conventional method (b). The two maps show the significant correlation (c), the yellow line is the linear regression, and the red
line is the 45 degree line. The difference map (d) of the two CBV is similar to the transfer constant map (e), especially in the tumor
region where the transfer constants are not zero (arrowheads). The CBV estimated by our algorithm is corrected for vascular
leakage, and thus is smaller than that by the conventional method.
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Given the single-voxel CNR of 18–50 (at the peak of
the curve) that typically can be achieved in dynamic
T2*-weighted images on a 1.5-T scanner, a few steps in
our algorithm are crucial to obtaining stable voxel-by-
voxel estimates of the transfer constant and CBV. First,
the difference in the width of the input function in a
voxel from that in normal white matter is omitted. This
omission is due to several considerations: 1) limited
CNR; 2) limited temporal resolution; and 3) a broaden-
ing in the width of the contrast concentration–time
curve in a voxel could also possibly be caused by vas-
cular leakage (Fig. 3a). Thus, if the width of the input
function for each voxel is allowed to vary freely, insta-
bility in fitting might result. On the other hand, the time
shift of the input function in each voxel can be deter-
mined relatively easily from the initial, rapidly rising
part of the curve, and there is no other parameter com-
peting for this information (Fig. 3). Thus, the time-shift
is adjusted for each voxel. Second, the initial voxel-by-
voxel estimate of vp (step two) is on principle similar to
the conventional CBV estimation when there is no vas-
cular leakage and no width change of the input function
in the voxel (16). The second part of the curve (after the
peak of the first pass), including the broadening and
elevation of the curve, is used for the initial estimates of
K
trans and kep. Third, an iterative process is used to
readjust v
p, K
trans and kep, since for a voxel that con-
tains leaky vessels v
p is potentially overestimated in
step 2 and subsequently K
trans is underestimated in
step 4.
CBV as estimated by our algorithm is well correlated
with that obtained from the conventional method (Fig.
5). The major differences between the two CBV maps
are located in the regions with tumor and/or large ves-
sels (Fig. 5d). Interestingly, but as expected, the pattern
of the difference of the two CBV maps qualitatively re-
sembles that of the transfer constant (Fig. 5e). In the
brain and/or tumor regions where blood-brain/tumor
barriers are disrupted and there is tissue uptake of the
contrast agent, the contrast concentration–time curves
are in general broadened and elevated (see Fig. 3a),
which have been assigned partially if not completely to
be a part of CBV by the conventional method. Our
algorithm attributes the broadened and elevated con-
trast concentration–time curves in tissue (compared to
that in normal white matter) to vessel leakage, and
consequently the transfer constant of the contrast
agent is estimated.
The averaged transfer constants of Gd-DTPA in the
grade IV glioma volumes ranged from 0.02 to 0.12
minute–1 with a group mean of 0.07 minute–1, which is
in the range of the values reported in the literature. In a
group of 10 patients with glioblastoma multiforme,
Johnson et al (8) found a mean transfer constant of
0.09 minute–1 using dynamic T2*-weighted images and
fitting the first pass only in the regions of interest
(ROIs). In that study, the transfer constants were esti-
mated within selected ROIs that showed the greatest
signal changes during the bolus arrival; whereas in our
study the transfer constants that were estimated voxel-
by-voxel were averaged over the voxels having nonzero
transfer constants (0.0002 minute–1) but within the
tumor volume. The heterogeneity of the transfer con-
stants in grade IV gliomas is well presented in Table 1,
in which the SD is almost as great as the mean for each
of the tumors. In 22 patients with gliomas, Roberts et al
(25) reported the significant correlation between grades
determined histologically and Gd-DTPA transfer con-
stants estimated by using a T1-based approach and
selecting the ROIs. If only grade IV gliomas in Robert et
al’s (25) study are considered, the averaged transfer
constant was 0.094 minute–1 (N  6), ranging from 0.4
to 0.13 minute–1, essentially in agreement with our
estimates. Using a modified T1 approach, Li et al (9)
estimated that transfer constants ranged from 0.07 to
0.01 minute–1, which were relatively smaller those re-
ported by Roberts et al (25), Johnson et al (8), and us.
Based upon our simulated data, the SD in estimates of
the transfer constant increased with noise and with a
decreased of the transfer constant (Fig. 6). For the 12
patients, the smallest averaged transfer constant in the
FLAIR tumor volume is 0.021 minute–1. For the transfer
constant 0.02 minute–1, our simulated data suggest
that the ratio of the SD to the mean of the transfer
Figure 6. The ratio of the SD to the mean of the transfer
constant as a function of the contrast to noise ratio at the peak












1 1.7 1.3 0.045 0.052
2 2.2 2.3 0.059 0.064
3 1.9 1.4 0.021 0.030
4 1.9 1.3 0.059 0.057
5 2.7 1.7 0.037 0.052
6 2.9 1.7 0.068 0.067
7 2.5 1.8 0.120 0.150
8 2.2 3.9 0.048 0.081
9 4.2 4.6 0.112 0.150
10 1.9 1.6 0.070 0.120
11 4.7 3.7 0.084 0.120
12 3.0 2.9 0.065 0.083
Mean  SD 2.7 1.0 0.066 0.029
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constant is less than 6%. This indicates that the heter-
ogeneity of the transfer constant in the tumor volume is
not predominantly due to noise.
It is difficult to differentiate susceptibility induced by
extravascular contrast from that arising form intravas-
cular paramagnetic contrast (26). The relationship be-
tween the contrast concentration and induced suscep-
tibility is complex, and may be influenced by the
contrast distribution. Therefore, in vitro calibration is
difficult to apply to in vivo data. The contrast agents
distributed in the extravascular extracellular space
most likely induce a T2* effect smaller than the contrast
contained in microvasculature (23). As a result, ne-
glecting this difference between intravascular and ex-
travascular contrast-induced susceptibilities may
cause an underestimation of the transfer constant.
In our computation, T1 enhancement (12) is not
taken into account. Our data were acquired with long
TR (two seconds), long TE (60 msec), 60° RF pulse, and
low contrast dose, and the signals never became nega-
tive within the 72 seconds acquisition time. Thus, T1
enhancement is a small effect, and most likely negligi-
ble. In step 3 of our algorithm, the contrast concentra-
tion–time curve in each voxel was compared to that in
normal white matter after normalization by the first
estimate of CBV. Only the voxels that show significant
broadening and elevation after the peak of the first pass
of the bolus compared to that in normal white matter
are considered to have nonzero leakage. This step
avoids fitting the transfer constant in the voxels where
the contrast concentration–time curve after subtracting
the intravascular contribution exhibits more noise than
signal (see Fig. 3b), since such fitting can result in large
errors in both the estimates of the CBV and the transfer
constant and can cause instability.
The proposed algorithm shows excellent stability. For
the single-voxel CNR of 20 or better that is routinely
obtained in clinic, our simulation shows that the ratio
of the SD to the mean is 11% or better for the transfer
constant greater than or equal to 0.01 minute–1. For the
transfer constant of 0.005 minute–1, the ratio increases
to 33% for CNR of 20. This latter increase in the SD of
simulation reflects the detectability for small transfer
constants using the current image acquisition param-
eters rather than the stability of the algorithm. The
detectability can be improved by increasing data acqui-
sition time to allow the contrast to infuse into tissue
without an increase in CNR. For example, if the acqui-
sition time is increased by 20 seconds, the ratio of the
SD to the mean decreases from 33% to14% for the
transfer constant of 0.005 minute–1 and CNR of 20.
In conclusion, the excellent stability of our algorithm
is essential for using vascular permeability as a metric
to evaluate a therapeutic regime (e.g., antiangiogenesis
and antitumor) in a clinical trial. This algorithm allows
us to retrospectively estimate the transfer constant of
vasculature to Gd-DTPA from the dynamic T2*-
weighted images that are widely used for estimates of
CBV and CBF in brain tumor clinic trials. Using a single
image acquisition, the three most important vascular
properties, CBV, CBF, and permeability, can be esti-
mated, thus avoiding two contrast injections. Our ap-
proach may also have potential in clinical evaluation of
patients with acute ischemic stroke, in which patient
population a blood-brain-barrier (BBB) permeability in-
crease can be an indicator of acute hemorrhage.
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